secwatch.observer — SEC 8-K summary
======================================

Issuer:     KalVista Pharmaceuticals, Inc. (KALV)
CIK:        0001348911
Form:       8-K
Filed at:   2022-12-27T23:59:59+00:00
Accession:  0001193125-22-312030
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KalVista raises ~$58M in registered direct offering of 9.48M shares at $6.00/share plus warrants
--------------------------------------------------------------------------------

- 9,484,199 shares at $6.00 per share, plus pre-funded warrants for 182,470 shares at $5.999 each.
- Net proceeds expected ~$58M for clinical trials, commercial development, R&D, and working capital.
- Offering closes Dec 28, 2022; post-closing shares outstanding ~34.1M (dilution of ~9.7M shares).
- No underwriter; securities offered under existing shelf registration (File No. 333-256378).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348911/000119312522312030/0001193125-22-312030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348911/000119312522312030/d420223d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-312030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer